Trade Mark Journal No.2025/025 20 June 2025

UK00004214340 5 June 2025 (10,44)

MYRIAD RISKSCORE

International priority date claimed: 10 December 2024 (European Union Intellectual Property Office (EUIPO)) (019117505)

Class 10: Apparatus for DNA and RNA testing for medical purposes; blood testing apparatus; testing apparatus for medical purposes; diagnostic apparatus for medical purposes; medical test kits for detection of gene mutations, gene variations, gene expression profiles or other molecular indicators or markers associated with disease or predisposition to developing disease.
Class 44: Medical screening services; medical testing services.

Myriad Genetics, Inc.

Representative: HGF Limited